TRUSHA BHATIA: Open Payments
NPI 1164198891 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 64 payments from 15 companies in 2025. Trend: 2023 $890 · 2024 $1,180 · 2025 $1,369
Food & beverage: $1,369
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $336 |
| ABBVIE INC. | 19 | $281 |
| Incyte Corporation | 6 | $161 |
| Galderma Laboratories, L.P. | 1 | $137 |
| Janssen Biotech, Inc. | 3 | $94 |
| Mallinckrodt Hospital Products Inc. | 2 | $57 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| MERZ NORTH AMERICA, INC. | 2 | $48 |
| LEO Pharma Inc. | 2 | $38 |
Products named: Bimzelx, SKYRIZI, OPZELURA, NEMLUVIO, TREMFYA, RINVOQ, ACTHAR, Zoryve.
Industry payments across IN — which companies pay providers there.
